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Abstract
iNKT cells are CD1d-restricted lipid-sensing innate T cells that express the transcription factor 
PLZF. iNKT cells accumulate in adipose tissue, where they are anti-inflammatory, but the factors 
that contribute to their anti-inflammatory nature, and their targets in adipose tissue are unknown. 
Here we report that adipose tissue iNKT cells have a unique transcriptional program and produce 
interleukin 2 (IL-2) and IL-10. Unlike other iNKT cells, they lack PLZF, but express the 
transcription factor E4BP4, which controls their IL-10 production. Adipose iNKT cells are a tissue 
resident population that induces an anti-inflammatory phenotype in macrophages and, through 
production of IL-2, controls the number, proliferation and suppressor function of adipose 
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regulatory T (Treg) cells. Thus, adipose tissue iNKT cells are unique regulators of immune 
homeostasis in this tissue.
iNKT cells have a semi-invariant αβTCR and recognize CD1d-presented lipid antigens1. 
Unlike adaptive MHC-restricted T cells, they display an effector and memory phenotype at 
steady-state, which renders them poised for immediate effector function. Because of their 
rapid response and basal expression of NK receptors they are considered “innate” T cells. 
iNKT cells characteristically express high levels of the BTB-POZ transcription factor PLZF, 
encoded by Zbtb16, this transcription factor was proposed to define the iNKT cell lineage2,3. 
PLZF is also expressed by human MAIT cells4, another population of semi-invariant T cells, 
as well as an innate subset of γδ T cells5. Thus, PLZF expression is associated with T cells 
with limited TCR diversity and is thought to be responsible for the innate phenotype and 
rapid cytokine response of these cells5.
MHC-restricted CD4+ T cells differentiate into TH1, TH2, TH17, and regulatory T (Treg) cell 
subsets. Likewise, subpopulations of iNKT cells analogous to Th1, Th2, and Th17 have 
been found, and they express some of the same transcription factors as the corresponding 
MHC-restricted T cells subsets. Surface markers such as CD4, NK1.1 and IL-17RB (a 
component of the IL-25 receptor) and cytokine receptors such as IL-12R and IL-23R can 
distinguish TH1-like, TH2-like and TH17-like iNKT cell functional subsets 6,7. However, 
iNKT cells can produce both TH1 and TH2 cytokines simultaneously, and functionally, 
while many iNKT cells are inflammatory and have important roles in host defense, they are 
also implicated in preventing or controlling autoimmune disease 8. iNKT cell production of 
IL-4, IL-10 and IL-13 has been linked to their capacity to suppress cell-mediated immune 
responses 9. iNKT cell numbers are reduced in humans with autoimmune diseases and 
mouse models of autoimmunity such as type I diabetes 10, multiple sclerosis 11,12 and 
systemic lupus erythematosus (SLE)13 and exacerbation or prevention of these conditions is 
seen in the absence or following activation of iNKT cells, respectively 14. However, a Treg-
like regulatory subset of iNKT cells has not been found.
In both mice and humans, iNKT cells are significantly enriched in visceral adipose tissue, 
where they represent 15–20% of total T cells15,16. Adipose tissue harbors a distinct 
collection of immune cells not seen elsewhere. Alternatively activated macrophages (M2) 
have an important role in the homeostasis of the adipose tissue at lean state17. Treg cells with 
a restricted TCR usage18 and a distinct gene expression profile that includes PPARγ and 
high IL-10 expression 19 accumulate in adipose tissue with age18. However, the 
development of obesity brings major changes to the adipose immune repertoire. iNKT cell 
numbers decrease early in human and murine obesity 15,16,20–22. Likewise, there is a drop in 
adipose Treg cell numbers18, while macrophages accumulate23 and undergo a phenotypic 
switch to the M1 pro-inflammatory macrophage type24. These changes result in a state of 
chronic inflammation that contributes to metabolic disease through inflammation-induced 
insulin resistance.
It was recently reported that adipose tissue iNKT cells play a protective role against obesity-
induced inflammation, glucose intolerance and weight gain through regulatory cytokine 
production 16,20,22,25–27. Yet, the basis for the protective function and the anti-inflammatory 
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nature of adipose tissue iNKT cells compared to the Th1, Th2 and Th17 inflammatory iNKT 
cells in other locations is not understood. Here, we show that unlike the vast majority of 
iNKT cells in other locations, adipose tissue iNKT display a unique transcriptome and are 
most notably characterized by the lack of PLZF expression. iNKT cell-deficient mice have 
reduced numbers of adipose tissue Treg cells, and we demonstrate that iNKT cells 
transactivate adipose Treg cells and regulate their function. Adipose iNKT cells also produce 
IL-10 in an E4BP4-dependent manner and can induce an M2 phenotype in macrophage. 
Thus, we define a new subpopulation of regulatory iNKT cells that have the ability to 
regulate the function on macrophages and Treg cells in adipose tissue.
Results
iNKT cells in adipose tissue are tissue resident
iNKT cells are enriched in human and murine adipose tissue, where their expression of CD4 
and NK1.1 is less than on iNKT cells elsewhere in the periphery15,16. To learn more about 
the nature of visceral adipose tissue iNKT cells, we investigated whether they are constantly 
replenished from the periphery, or if they represent a tissue-resident population. To address 
this we generated parabiotic pairs of CD45.1 and CD45.2 congenic mice. During the healing 
process after surgery, capillary anastomoses form between the two vascular systems, 
allowing for exchange of circulating peripheral blood cells. In this experimental system, 
MHC-restricted CD4+ and CD8+ T cells and B cells rapidly recirculated to reach 
equilibrium (equal chimerism) in the blood and spleen of parabiotic mice after 2 weeks (Fig. 
1a), while bone marrow and thymic cell progenitors do not exchange at this time28. 
However, the parabiotic reconstitution was lower in the liver and adipose tissue, suggesting 
resident lymphocyte populations with low turnover reside in these locations (Fig.1a). To 
identify the circulating or resident behavior of each lymphocyte population, we examined 
the chimerism of various lymphocyte subsets. B cells, CD8+ T cells and CD4+T cells 
recirculated though blood, spleen, liver and adipose tissue, reaching almost equal (50%) 
chimerism between CD45.1 and CD45.2, indicating almost full exchange (Fig. 1b). Adipose 
Treg cells recirculated to a lesser degree, with only 25% of cells originating from the 
parabiotic partner of each mouse, although almost complete Treg cell chimerism was seen in 
the blood, spleen and liver (Fig. 1b). This suggests that Treg cells constantly recirculate 
through some organs, but also make up resident populations in selected tissues. In contrast 
to all the other lymphocyte populations, iNKT cells showed virtually no circulation in any of 
the organs examined (Fig. 1b). In the adipose tissue, >95% of iNKT cells were derived from 
the host (Fig. 1b, c), indicating that iNKT cells are a tissue-resident lymphocyte population 
in adipose tissue.
Because ICAM1-LFA1 interactions are critical for iNKT cell retention in the liver29–31 we 
investigated if LFA1 and ICAM1 molecules were responsible for iNKT accumulation and 
retention in adipose tissue. Icam1tm1Alb mice had less iNKT cells than wild-type mice in the 
liver, confirming the importance of ICAM1 in retention of hepatic iNKT cells. However, 
iNKT cells were present at normal to slightly elevated frequency and similar absolute 
numbers in adipose tissue of ICAM1-deficient mice compared to wild-type (Fig. 1d,e). 
Furthermore, in vivo blocking of ICAM1 and LFA1 with neutralizing antibodies resulted in 
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iNKT cell egress from the liver, but not from the adipose tissue (Fig. 1f). Thus, adipose 
iNKT cells are a tissue-resident population that do not rely on iCAM1-LFA1 interactions for 
their retention in adipose tissue.
Adipose iNKT cells have a unique gene expression program
Adipose tissue iNKT cells show phenotypical and functional differences to other iNKT 
cells, including low CD4 and NK1.1 expression, low IFN-γ, production, and production of 
IL-1016,20, which together with the observation that they are tissue resident, suggest they 
may represent a unique population. High-resolution expression analysis comparing iNKT 
cells to other leukocyte populations, as well as iNKT cells in different tissues as part of the 
Immunological Genome Project Consortium (Immgen) revealed that only a small numbers 
of genes were different between iNKT cells from liver, spleen and thymus (eg. liver and 
splenic iNKT differed by ~100 genes)32. Microarray gene expression analysis of visceral 
adipose iNKT cells revealed that adipose iNKT cells overexpressed 639 genes compared to 
matched splenic iNKT cells (Fig. 2a), suggesting they may represent a distinct iNKT 
population. The overexpressed genes included the MAP kinase phosphatase Dusp1, nuclear 
receptor transcription factor Nur77 (Nr4a1), and the basic leucine zipper transcription factor, 
E4BP4 (Nfil3). In addition, 2,710 genes were under-represented in adipose iNKT cells 
compared to splenic iNKT cells. PLZF(Zbtb16), a transcription factor reported to be 
expressed by all iNKT cells examined up to now 2,3, was not substantially expressed by 
adipose iNKT cells, as was IL-7R (Fig. 2a). In contrast, PLZF was highly expressed on 
splenic iNKT cells (Fig. 2a), similar to previous reports for hepatic, splenic and thymic 
iNKT cells3,5,32. PLZF transcripts were just above the expression cutoff point in adipose 
iNKT cells (Fig. 2b). To analyze the expression of the PLZF protein in the adipose tissue 
iNKT cells, we used PLZF-GFP reporter mice (PEG) generated using modified bacterial 
artificial chromosome transgene expressing eGFP under the control of PLZF regulatory 
elements. Flow cytometric analysis revealed that adipose tissue iNKT cells had very low 
GFP expression, while iNKT cells in liver and thymus were GFP+ (Fig. 2c). We next asked 
if adipose tissue iNKT cells express PLZF in younger mice. The youngest age at which we 
could detect epididymal adipose tissue in mice was ~ 12 days old (not shown), when it is 
thought that iNKT cells start to populate the periphery33. iNKT cells were first detectable in 
the mouse adipose tissue at 2 weeks of age, and increased with age to represent 5% of T 
cells at 2 weeks and ~20% of T cells at 16 weeks (Fig. 2d). However, adipose iNKT cells 
had low or negligible GFP expression in 2 week old PLZF-GFP mice, while total thymic 
and liver iNKT cells were GFP+ in mice of all ages examined (Fig. 2e). Mean fluorescence 
intensity (MFI) of GFP showed that adipose iNKT cells had very low PLZF expression 
compared to iNKT cells in thymus, liver and spleen at all ages examined, however, 
conventional T cells (TCRβ+ CD1d-aGalCer tetramer−) in adipose tissue had even lower 
PLZF expression (Fig. 2f). Thus, iNKT cells in the adipose tissue express very little PLZF at 
all ages.
We next investigated the possibility that adipose tissue iNKT cells lose PLZF expression 
following migration out of the thymus. Athymic nude mice, which lack all T cells, including 
iNKT cells, had no iNKT cells in the adipose tissue (Supplementary Fig. 1), confirming the 
thymic origin of this iNKT cell subset. Next, to determine if adipose tissue iNKT cells had 
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expressed high amounts of PLZF at previous developmental stages, we crossed PLZF-Cre 
mice, which express a BAC transgene in which a Cre recombinase is knocked into the PLZF 
gene, with mice expressing the fluorescent marker tdTomato encoding a floxed stop codon 
at the ROSA26 locus. In PLZF-Cre x Rosa26fl/fl mice, cells that express PLZF (and 
therefore Cre) are permanently tdTomato+. Spleen and adipose tissue iNKT cells in the 
PLZF-Cre x Rosa26fl/fl mice were highly positive for tdTomato (Supplementary Fig.2), 
indicating that adipose tissue iNKT had expressed PLZF during development .and 
downregulated it in the thymus or at a later stage. However, PLZF mRNA is also transiently 
expressed in HSCs and as a result, 50% of all splenocytes, of which only 1–3% are iNKT 
cells in the PLZF-Cre x Rosa26fl/fl mice are tdTomato positive. Thus, these experiments do 
not indicate at what stage in the development of adipose tissue iNKT cells was PLZF 
functionally important, if at all.
To determine if PLZF is required for adipose tissue iNKT development, we used PLZF-
deficient mice. Despite the transient expression of PLZF in HSCs, Zbtb16tm1Ppp (referred to 
from here as PLZF−/−) have a selective and severe deficiency in iNKT cell development, 
with very few iNKT cells still present, while other lymphocytes are unaffected 2,3. Both 
PLZF−/− and PLZF+/− mice had a substantially reduced numbers of thymic and peripheral 
iNKT cells (Fig. 2g). We observed a 50–85 % reduction in the number of iNKT cells in the 
spleen, liver and thymus of PLZF+/− mice compared to wild-type littermates, while there 
was no significant decrease in the number of iNKT cells in adipose tissue of PLZF+/− mice 
compared to wild-type (95% of wild-type; Fig. 2g). PLZF−/− mice had a 80–90% reduction 
in the number of iNKT cells in spleen, liver and thymus compared to wild-type mice, while 
iNKT cells numbers in the adipose tissue were reduced by 50% compared to wild-type mice 
(Fig. 2g). These data suggests that at steady state, the iNKT cells in the adipose tissue are 
less sensitive to genetic deletion of PLZF compared to other peripheral sites, although 
homeostatic proliferation/survival may compensate for PLZF deficiency specifically in 
adipose tissue.
We next asked if adipose tissue iNKT cells expressed the canonical Vα14-Jα18 TCR paired 
with Vβ7, Vβ8.1 or Vβ8.2. Single cell PCR showed that iNKT cells in adipose tissue 
expressed the invariant Vα14-Jα18 TCR, paired with a limited Vβ gene repertoire 
(Supplementary Fig. 3). Thus, our findings indicate that a population of PLZFlow iNKT that 
are less sensitive to genetic deletion of PLZF accumulate in adipose tissue.
Adipose iNKT cells are phenotypically similar to iNKT cells in PLZF−/− mice
The first detectable iNKT cell precursors believed to immediately follow positive selection 
in the thymus (stage 0) are CD24hi CD1d-tetramer+ cells that uniformly express CD69 34. 
iNKT cells then progress to CD24low cells and subsequently develop into CD44lowNK1.1− 
(stage 1), CD44hiNK1.1− (stage 2) and CD44hiNK1.1+ (stage 3) cells 34. Stage 0 precursors 
are PLZF positive, although they have a low frequency in the thymus 2. As previously 
reported 2,3, we found that the low number of iNKT cells present in the PLZF−/− and 
PLZF+/− thymi and periphery were arrested at stage 1, based on their CD44lo NK1.1lo 
phenotype (Fig. 3a). Similar to thymic and peripheral iNKT cells from the PLZF−/− and 
PLZF+/− mice, adipose tissue iNKT cells in the wild-type mice were mainly CD44low 
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(~80% , compared to 8–20% in thymus and liver), and ~40% of them were NK1.1−, in 
contrast to only ~15% NK1.1− iNKT cells in the liver (Fig. 3a,b). Thus, wild-type adipose 
tissue iNKT cells share a number of key phenotypic markers with liver and spleen PLZF-
deficient iNKT cells.
PLZF expression is required for the innate-like effector program of iNKT cells, including 
rapid production of IFN-γ after stimulation. IFN-γ production by iNKT cells is diminished 
or absent in PLZF−/− mice, while their production of IL-2 is enhanced2. Microarray 
expression analysis in adipose iNKT cells showed high expression of IL-2 mRNA, 
compared with iNKT cells in thymus, liver and spleen (Fig. 3c). Furthermore, adipose tissue 
iNKT cells produced more IL-2 after stimulation with PMA and Ionomycin compared to 
splenic iNKT cells (Fig. 3d). However, IL-2 production by wild-type adipose tissue iNKT 
cells was lower than PLZF−/− adipose tissue iNKT cells after PMA+ Ionomycin stimulation 
(Fig. 3e), suggesting complete loss of PLZF in adipose tissue iNKT cells has an effect on the 
phenotype of these cells. However, wild-type adipose tissue iNKT cells do not express 
IL-2R mRNA, as assessed by RT-PCR (Fig. 3f), or the CD25 protein (data not shown), 
unlike splenic iNKT cells and adipose Treg cells, which have high IL-2R expression (Fig. 
3f). Thus, adipose tissue iNKT cells, like iNKT cells from PLZF−/− mice, express low levels 
of NK1.1 and CD44, and have a strong functional capacity to produce IL-2.
Adipose iNKT cells express T-bet and Gata-3, similar to other iNKT cells
Based on their expression of transcription factors T-bet, Gata-3 and Rorγt and various 
cytokines, iNKT cells are currently grouped into four functional subsets: NKT1, NKT2, 
NKT1735–37 and NKT-FH38 cells. Intranuclear staining showed that, similar to iNKT cells 
in thymus, spleen and liver, adipose tissue iNKT expressed Gata-3 and T-bet, but 
undetectable Rorγt (Supplementary Fig. 4a), unlike splenic subsets of NKT17 cells (not 
shown). Adipose tissue iNKT cells produce little IFN-γ after αGalCer stimulation in vivo or 
in vitro16. However, similar to splenic or hepatic iNKT cells, we observed basal IFN-γ 
mRNA expression in adipose tissue iNKT cells (data not shown), suggesting that adipose 
tissue iNKT cells can produce IFN-γ. To determine the cytokine production potential of 
adipose tissue iNKT cells, we stimulated total spleen, liver and adipose tissue leukocytes 
with either αGalCer or PMA+Ionomycin, and simultaneously added brefeldin A, which 
blocks protein transport from the endoplasmic reticulum, for 5 hours, followed by CD1d-
tetramer gating and intracellular cytokine staining. Adipose tissue iNKT cells did not 
produce detectable IFN-γ protein, but, unlike splenic and hepatic iNKT cells, they produced 
IL-10 after αGalCer stimulation (Supplementary Fig. 4b). However, after PMA + 
Ionomycin stimulation, adipose iNKT cells produced high amounts of IFN-γ, TNF and 
IL-10, but little IL-4 (Supplementary Fig. 4c). Adipose tissue iNKT cells did not produce 
IL-17A following either αGalCer or PMA + Ionomycin stimulation (Supplementary Fig. 
4c). Thus, although adipose iNKT cells express the machinery for IFN-γ production and are 
capable of producing IFN-γ under mitogenic conditions, they produce IL-10 and not IFN-γ 
when stimulated with a strong lipid ligand.
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IL-10 production in adipose iNKT cells is controlled by E4BP4
We next investigated the transcription factors that control IL-2 and IL-10 expression in the 
adipose tissue iNKT cells. E4BP4, encoded by the Nfil3 gene, is known to regulate IL-10 
expression in TH1, Treg and NKT cells 6,39. By microarray analysis, we found that E4BP4 
transcript was highly expressed in adipose tissue iNKT cells, but not in liver and spleen 
iNKT cells, while thymic iNKT cells expressed very low amounts (Fig. 4a). Intranuclear 
mAb staining showed E4BP4 protein expression in adipose tissue iNKT cells, but not in 
iNKT cells in liver, spleen, thymus, bone marrow, lymph node and blood (Fig. 4b). Adipose 
tissue Treg cells also expressed E4BP4 mRNA transcripts (Fig. 4a) and E4BP4 protein, as 
detected by intracellular E4BP4 mAb staining, at levels similar to adipose iNKT cells (Fig. 
4c). Conventional CD8+ T cells and (non-regulatory) CD4+ T cells did not express E4BP4 
(Fig. 4d). Flow cytometry confirmed that adipose tissue iNKT cells were not Treg cells, 
based on their lack of Foxp3 expression (Fig. 4e). Adipose Treg cells have high IL-10 
mRNA expression (not shown, data available on Immgen.org), while adipose tissue iNKT 
cells produced IL-10 protein following in vivo injection of αGalCer (Fig. 4f). To determine 
if E4BP4 was required for IL-10 production in iNKT cells, we transfected in vitro-cultured 
primary splenic iNKT cells, which are E4BP4−, with E4BP4 (Fig. 4g). E4BP4 expression 
induced IL-10 production in αGalCer-stimulated splenic iNKT cells (Fig. 4h), as measured 
by intracellular cytokine staining and RT-PCR, whereas mock-transfected splenic iNKT 
cells did not express IL-10 after stimulation (Fig. 4i). Thus adipose iNKT cells, unlike 
splenic and hepatic iNKT cells, express the transcription factor E4BP4, which is responsible 
for IL-10 production.
Adipose iNKT cells regulate adipose resident macrophages
Through their rapid cytokine production, iNKT cells are potent transactivators of immune 
cells and act as a bridge between innate and adaptive immunity. We next investigated the 
effects of adipose iNKT cell-derived IL-2 and IL-10. Firstly, to address the localization of 
iNKT cells in the wild-type adipose tissue at steady-state or after αGalCer activation, we 
developed an αGalCer-loaded CD1d tetramer labeling technique that allows detection of 
iNKT cells in situ in fresh tissues by confocal microscopy. CXCR6-reporter mice have 
previously been used to visualize hepatic iNKT cells30. By αGalCer-loaded CD1d tetramer 
staining we confirmed that the majority (>90%) of CXCR6+ cells in the adipose tissue were 
iNKT cells (Fig. 5a and data not shown) and therefore we used CXCR6-GFP reporter mice 
to image iNKT cells in the adipose tissue. We found that CD1d tetramer+ cells (which were 
also CXCR6-GFP+) were broadly dispersed throughout adipose tissue at steady state (Fig. 
5a, b), while following αGalCer stimulation iNKT cells formed numerous clusters in the 
adipose tissue (Fig. 5a). Co-staining of wild-type mouse adipose tissues showed that iNKT 
cells interacted with CD11b+ macrophages at steady state, particularly with CD301+ M2 
macrophages (Fig. 5b). Following αGalCer stimulation, iNKT cells and CD11b+ 
macrophages formed clusters around and between adipocytes (Fig. 5b). iNKT cells co-
localization with macrophages increased from ~20% at steady-state to 50% of iNKT cells 
after αGalCer treatment (Figure 5c). Lack of iNKT cells was shown to induce a pro-
inflammatory environment in obese adipose tissue, including increased numbers of pro-
inflammatory macrophages16,20. Furthermore,IL-10 blocking prevents some of the 
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beneficial effects of αGalCer stimulation on metabolism16. To address if iNKT cell-derived 
IL-10 directly influences macrophage pro- or anti-inflammatory profiles in lean mice, we 
assessed the expression of the M2 markers CD206 and CD301, and the M1 marker CD11c 
on adipose tissue macrophages 3 days after treatment of wild-type lean mice with PBS or 
αGalCer. Immunohistochemstry showed that αGalCer induced an increase of CD206+ 
macrophages within 3 days compared to PBS treated mice (Fig. 5d). By flow cytometry, we 
saw a decrease in the frequency of CD11c+ M1 macrophages and a significant increase in 
the frequency of CD206+ (22 to 38%) and CD301+ (35–50%) M2 macrophages in αGalCer 
compared to PBS treated mice (Fig. 5e). Whole adipose tissue qPCR analysis showed that 
αGalCer reduced iNOS mRNA expression in wild-type, but not in CD1d−/− mice (Fig. 5f). 
Furthermore, CD1d−/− mice had more CD11c+ M1 macrophages (Fig. 5g) and more iNOS+ 
macrophages compared to WT mice (Fig. 5h), as measured by flow cytometry. To determine 
if iNKT derived-IL-10 was responsible for macrophage M2 polarization in the adipose 
tissue, we neutralized IL-10 at the time of αGalCer treatment. The decrease in CD11c+ 
macrophages frequency after αGalCer treatment occurred independently of IL-10, however, 
the increase in the frequency of CD206+ and CD301+ M2 macrophages was prevented by 
IL-10 neutralization (Fig. 5i). αGalCer treatment also induced the upregulation of IL-10R on 
adipose tissue macrophages, which was also prevented by IL-10 neutralization (Fig. 5i). 
Thus, iNKT cells interact with macrophages at steady state and after αGalCer stimulation, 
and activation of adipose tissue iNKT cells with αGalCer induces IL-10R upregulation and 
the M2 polarization of adipose macrophages in lean mice.
Adipose iNKT cells regulate adipose Treg cells
Treg cells have high expression of CD25 and require IL-2 for survival and proliferation40. 
Therefore, we investigated whether IL-2 production by iNKT cells influence Treg cells 
function in the adipose tissue. First, we assessed if in vivo αGalCer stimulation of iNKT 
cells in wild-type mice had an effect on adipose tissue Treg cells. Three days after αGalCer 
treatment, adipose Treg cells increased in frequency (from 3 to 7% of lymphocytes, or from 
15% to 30% of CD4+ T cells) and in absolute number (from 10,000 to 50,000 per 2 fat pads; 
Fig. 6a–d). In contrast, in the spleen, where iNKT cells do not produce IL-2, splenic Treg 
cell numbers did not increase after αGalCer administration (Fig. 6e). We also assessed Treg 
cells expansion after αGalCer administration to Foxp3-GFP reporter mice. Treg cells were 
sparse and difficult to detect by GFP immunofluorescence in the adipose tissue of 6 to 16 
weeks old naïve Foxp3-GFP mice. Following αGalCer administration, GFP+ Treg cells were 
observed within iNKT cell clusters in adipose tissue (Fig. 6f). To address if the 
transactivation of Treg cells occurs within the iNKT cells clusters, we examined Treg cell 
numbers in the adipose tissue of CD1d−/− and Ja18−/− mice at steady state. Treg cells 
frequencies were significantly decreased in the adipose tissue of CD1d−/− mice (1.6%) 
compared to wild-type (4% of lymphocytes; Fig. 6g). Nuclear Ki67 staining showed that 
Treg cells proliferated less in adipose tissue of CD1d−/− mice at steady state compared to 
wild-type mice (Fig. 6h). Treg cell frequencies were also significantly reduced in adipose 
tissue of young and old Ja18−/− mice compared to wild-type mice (Fig. 6i). To test if iNKT 
cells-derived IL-2 was critical for Treg cell regulation in the adipose tissue, we neutralized 
IL-2 in αGalCer-treated wild-type mice. IL-2 blocking prevented the αGalCer -induced 
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expansion of adipose tissue Treg cells in vivo (Fig. 6j). These data suggest that activation of 
iNKT cells transactivates adipose Treg cells and regulates their homeostasis.
iNKT cells in adipose tissue are regulatory
Next we addressed whether adipose tissue iNKT cells induced macrophage M2 polarization 
directly or indirectly, through Treg activation and IL-10 production. Adipose tissue Treg cells 
express high amounts of IL-10 at resting state18, and have a higher expression of the lectin-
like inhibitory receptor Klrg1compared to Treg cells in other tissues, indicative of strong 
anti-inflammatory and suppressive functions. Klrg1 expression is thought to be IL-2 
dependent and identifies a population with enhanced suppressive function 41. Flow 
cytometry analysis showed that adipose tissue Treg cells expressed high amounts of Klrg1 
protein (57%, compared to 5% on splenic Tregs; Fig. 7a). Klrg1 expression on adipose tissue 
Treg cells increased following αGalCer treatment (Fig. 7a) while Treg cells in CD1d−/− mice 
expressed significantly less Klrg1 than wild-type in the adipose tissue (Fig. 7a). 
Furthermore, adipose Treg cells had enhanced production of IL-10 after αGalCer treatment 
compared to mice that received PBS (Fig. 7b). At steady state, there were significantly fewer 
Treg cells producing IL-10 in Ja18−/− iNKT cells deficient mice (Fig. 7c). To further test the 
hypothesis that iNKT cells can enhance Treg cell functions, we co-cultured peritoneal 
macrophages with freshly isolated adipose tissue Treg cells from wild-type lean mice treated 
with PBS or αGalCer for 3 days. All adipose tissue Treg cells induced the expression of M2 
markers on cultured macrophages, whileTreg cells from αGalCer-treated mice had enhanced 
ability to induce M2 macrophage marker expression compared to PBS treatment (Fig. 7d). 
These results suggest that iNKT cells can regulate the number and function of adipose Tregs 
cells.
We also investigated if adipose iNKT cells could induce M2 macrophage polarization 
directly. We found that adipose iNKT cells had high expression of Klrg1 mRNA (not 
shown) and expressed more cell surface Klrg1 (30%) compared to splenic iNKT cells (2%; 
Fig. 7e). Adipose iNKT cells also expressed more ICOS (7%, compared to 1% on splenic 
iNKT) and PD1 (16%, compared to 2% on splenic iNKT; Fig. 7e), suggesting that adipose 
iNKT cells, but not splenic iNKT cells share some phenotypical markers with Treg cells. To 
test the regulatory functions of adipose iNKT cells, we cultured freshly isolated iNKT cells 
and Tregs from wild-type mouse adipose tissues with peritoneal macrophages. iNKT cells 
alone were sufficient to induce the expression of M2 macrophage markers on cultured 
macrophages, similar to, although not as strongly, as adipose Treg cells (Fig. 7f). iNKT cells 
isolated from spleen had no regulatory potential, although splenic Treg cells did, as expected 
(Supplementary Fig. 5). Co-culture with either adipose Treg cells or iNKT cells significantly 
reduced the frequency of iNOS-producing macrophages compared to culture with media 
alone (Fig. 7g). These data indicate that adipose iNKT cells can directly induce M2 anti-
inflammatory macrophages, and also enhance the ability of Treg cells to do the same.
Discussion
Here we describe a population of PLZFneg/lo iNKT cells resident in adipose tissue, that are 
Foxp3 negative but regulatory in nature. Adipose PLZFneg/lo express E4BP4, produce IL-2 
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and IL-10 and control adpose Treg cells and macrophages locally, making them important 
regulators of immunity in adipose tissue. iNKT cells are can act as cellular adjuvants that 
enhance immune responses and bridge the innate and adaptive immune systems. Although 
iNKT cells express a canonical TCR, they are a heterogeneous population. They respond 
differently under specific conditions, and have tissue specific responses. Therefore, the 
ability of iNKT cells to produce various cytokines, and subsequently skew an immune 
response is due either to the microenvironment in which they are activated, and/or to the 
existence of functionally distinct iNKT-1,-2, −17 and NKT-FH cell subsets6,35,37,38. Our 
findings using parabiosis pointed to the tissue resident nature of adipose iNKT cells. Based 
on their transcription factor profile, including the very low PLZF levels, and expression of 
E4BP4, adipose iNKT cells do not fall into the NKT-1, NKT-2, NKT-17 or NKT-FH cell 
subsets previously described. A population of NKT cells expressing both PLZF and FoxP3 
in cervical lymph nodes following aGalCer administration have been reported in a EAE 
model42, suggesting that regulatory iNKT cells can be induced in specific settings. 
However, we found that adipose iNKT cells do not express Foxp3. Thus, adipose iNKT cells 
are a distinct regulatory subset based on their phenotype, transcriptional program and 
function.
The adipose tissue PLZFlo iNKT cell subset may develop towards this distinct phenotype in 
the thymus before migration to adipose tissue. Alternatively, this subset may represent a 
state of activation. iNKT cells in the rest of the body are found in a poised state, ready for 
rapid cytokine production following activation. In contrast to these other sites, our data 
suggests that adipose iNKT cells may be chronically activated. At steady state, we found 
that adipose tissue iNKT cells lack IL-7R and express high amounts of CD69 and Nur77, 
which are hallmarks of activation through TCR stimulation43. In addition, cultured iNKT 
cell clones decrease their PLZF expression after stimulation44. Therefore, signals in the 
adipose tissue may sustain this iNKT cell subset as chronically activated. These may include 
lipid antigens, cytokines or adipokines that may provide co-stimulatory signals to iNKT 
cells in the presence of endogenous lipid antigens. CD1d is expressed in human adipose 
tissue15. Adipocytes themselves express CD1d21,22, and therefore may function as antigen 
presenting cells for iNKT cells. However, if iNKT cells were chronically activated in the 
adipose tissue, one might expect them to be in an anergic state. Although more adipose 
iNKT cells express PD1 than splenic iNKT cells, our data suggests that adipose iNKT cells 
are not anergic, as they proliferate massively and produce cytokines in vivo after αGalCer 
injection. It was recently reported that iNKT cells pre-treated with αGalCer, which are 
typically thought to become hyporesponsive, were still capable of proliferating and 
produced cytokines, namely IL-1045, suggesting these cells had not become anergic, but 
rather immunoregulatory, subsequent to strong stimulation. The same report found a 
functionally similar population enriched in adipose tissue without αGalCer treatment45, 
lending strength to the hypothesis that adipose iNKT cells may be alternatively activated due 
to chronic stimulation locally. Adipose iNKT cells also appear less dependent on PLZF 
expression for their development or local homeostasis compared to other iNKT subsets. 
First, they express very little PLZF and second, there was no significant reduction in adipose 
iNKT cell numbers in PLZF+/− mice. Studies using haplosufficient PLZF mice have shown 
that high levels of PLZF expression were required for the effector functions of other iNKT 
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cells2,3,44 and development, evidenced by a severe decrease of iNKT cell numbers in the 
periphery in PLZF+/− mice. It remains to be seen whether there is a compensatory 
mechanism in haplosufficient PLZF mice in the adipose tissue, or whether high levels of 
PLZF would be required for iNKT cell development, traffic or survival in adipose tissue, in 
a similar way to what is required for iNKT cells in the liver and spleen.
Adipose tissue is a site of constant remodeling with fluctuations in lipid handling, storage 
and lipolysis, due to the fasting and feeding cycles that occur in mice and humans, or in 
more extreme examples, during famine or obesity. The adipose resident immune system 
seems to function in an anti-inflammatory state to dampen inflammation during potentially 
dangerous remodeling, where foreign dietary derived lipids must be tolerized, and also 
buffered to prevent lipotoxicity. Adipocytes play an important role in buffering lipids from 
the immediate environment, and also from preventing lipid spillover to ectopic sites like 
liver and muscle. However, the immune system, particularly macrophages, have also been 
implicated in preventing lipotoxicity and in buffering lipids46. We suggest that enrichment 
of regulatory iNKT cells in adipose tissue helps to keep inflammation at bay, and at the 
same time, to regulate the homeostasis of other anti-inflammatory immune cells including 
M2 macrophages and Treg cells.
This scenario fits perfectly with a protective role for adipose iNKT cells in obesity, although 
the beneficial role of iNKT cells in obesity is currently controversial47,48 due to variations in 
the metabolic phenotype of iNKT deficient mice. However, several studies have shown 
adoptive transfer of iNKT cells into obese iNKT-deficient mice16 or activation of iNKT 
cells by αGalCer in obesity dampens inflammation, leading to improved metabolic outcome 
and weight loss16,20,22,27. However, the mechanism of action of adipose iNKT cells, as was 
the basis for their anti-inflammatory nature, remained unclear. Our current study sheds light 
on the mechanisms of action for iNKT cells in adipose tissue, and therefore has important 
implications in obesity and associated metabolic disease. The anti-inflammatory and 
regulatory nature of adipose iNKT cells suggests that they can influence the functions of 
macrophages and Tregs cells directly, as well as functioning as regulatory cells themselves. 
The observed depletion of adipose iNKT cells in human and murine obesity15,16,20–22 
therefore represents the loss of an important regulatory population. Without adipose 
regulatory iNKT cells, Treg cell numbers and M2 macrophage status are compromised, both 
of which impact adipose tissue inflammation and metabolic disorder that accompanies 
obesity. The capacity of iNKT cells to activate rapid cytokine production has been exploited 
to manipulate the outcomes of mouse models of autoimmunity and cancer various 
cancers8,13,49. Our findings indicating that adipose iNKT cells maintain a healthy adipose 
tissue under normal conditions suggest they may be a potential therapeutic target to correct 
obesity and metabolic disorder.
Online Methods
Mice
C57BL/6, mice were purchased from Jackson Laboratory. CD1d−/− were provided by Mark 
Exley (Harvard Medical School). C57BL/6 CXCR6-GFP+/− mice (The Jackson Laboratory) 
and C57BL/6 Foxp3gfp mice50 (founders were kindly provided by Dr. Alexander Rudensky 
Lynch et al. Page 11
Nat Immunol. Author manuscript; available in PMC 2015 July 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
at the Memorial Sloan-Kettering Cancer Center) were bred and maintained at the Trudeau 
Institute and were used at 8–16 weeks of age. PLZF-deficient mice (were kindly provided by 
Dr. Pier Paulo Pandolfi) and have been described3. PLZF-reporter (PEG) mice were 
generated in the Sant’Angelo lab with a modified bacterial artificial chromosome transgene 
expressing eGFP under the control of PLZF regulatory elements. The pLD53 SC-AB vector 
system (provided by Dr. E. Pamer, MSKCC, New York, NY) was used for the modification. 
The purified bacterial artificial chromosome transgene was microinjected into fertilized 
C57BL/6 eggs by MSKCC’s Mouse Genetics Core Facility. EGFP expression faithfully 
reproduced PLZF expression in all three founder lines. One was selected for further 
experiments. PCre mice were generated with similar methodology with a bacterial artificial 
chromosome transgene expressing Cre recombinase under the control of PLZF promoter. In 
almost all experiments, male mice were used, with the exception of PLZF+/− and −/− mice 
and Jα18−/− where male and female mice were used and compared to male a female WT 
mice. Mice were bred in our specific-pathogen-free facilities at Harvard Medical School. All 
animal work was approved by and in compliance with the Institutional Animal Care and Use 
Committee guidelines of The Dana Farber Cancer Institute and Harvard Medical School.
Tissue processing
The visceral abdominal fat was isolated from the mice and digested with 20 mL collagenase 
solution (1mg/mL collagenase in PBS) at 37°C for 25 min with shaking. After digestion, 
adipocytes were isolated by filtering through a 40um nylon mesh and centrifuged for 5 min 
at 300g to pellet the stromovascular fraction (SVF). The supernatant was discarded and the 
SVF was washed with FACS buffer (1%FBS and 0.02% NaN3 in PBS), then resuspended in 
FC block at 4°C for 15 min and then stained with desired antibodies.
Parabiosis surgery
CD45.1 and CD45.2 mice were anesthetized with 100 mg/kg ketamine and 10 mg/kg 
xylazine. After shaving, a linear incision was made from the scapulae to the lower abdomen 
on opposing sides of each member of the pair. Animals were placed side-by-side and skin 
edges sewn together. Each pair was housed singly, with food placed on the floor of the cage 
for the first week during recovery. Parabiotic mice were kept together for 2–3 weeks. 
Percent chimerism in the blood and tissues was defined for gated lymphocytes, or 
lymphocyte subsets as the percentage of CD45.1+ cells over the percentage of CD45.1+ plus 
CD45.2+ cells in CD45.2+ mice and as the percentage of CD45.2+ cells over the percentage 
of CD45.2+ plus CD45.1+ cells in CD45.1+ mice.
Microarray
iNKT cells were sorted on a FACSAria (BD) by the Flow Cytometry Core of The Dana-
Farber Cancer Institute. Cells were double-sorted to >95% purity and collected into TRIzol 
(Invitrogen). Sample processing and data analysis were performed as previously 
described32. Expression plots were produced with GenePattern.
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Single-cell PCR
cDNA from sorted CD1d-α-GalCer tetramer+ TCRβ+ cells was generated by the addition of 
2µl per well of buffer containing SuperScript VILO (Invitrogen) and 0.1% Triton X-100 
(Sigma), and incubated according to manufacturer’s instructions. Transcripts encoding Vα 
and Vβ were amplified by two rounds of nested PCR as previously described (paper 
reference below). PCR products were separated on a 1.5% agarose gel and sequenced 
(Applied Genetics Diagnostics, University of Melbourne).
Confocal/fluorescent microscopy
For detection of GFP and PBS57-CD1d tetramer staining, epididymal or subcutaneous 
adipose tissue was harvested into PBS/0.02% sodium azide /5% normal mouse serum 
(Jackson ImmunoResearch Laboratories, Inc.). Tissues were first stained with PBS57 
loaded-CD1d tetramers (provided by the NIH Tetramer Core Facility) at room temperature 
for 60 min in the dark on a circular shaker. Subsequent antibody staining was performed on 
ice for 60 min, in the dark on a circular shaker. Next, tissue was washed with PBS/ 0.02% 
sodium azide/ 5% mouse serum. Adipose tissue was imaged on glass slides with Aqua Poly/
Mount (Polysciences, Inc.) and a coverslip by confocal microscopy (Leica TCS SP5). 
Surface antibody staining included anti-CD11b (M1/70) from eBioscience, anti-CD4 
(RM4-5) and anti-CD301 (LOM-14) from Biolegend.
Flow cytometry and cell sorting
Single-cell suspensions were incubated with Fc receptor-blocking antibody before being 
stained on ice with specific antibodies and tetramer. Dead cells were excluded with live/
dead gate using 7-AAD, or Zombie Aqua (BioLegend) for fixed and permeabilized cells. 
αGalCer analog PBS-57-loaded or empty CD1d tetramers were provided by the NIH 
tetramer facility (Emory Vaccine Center, Atlanta). For analysis of iNKT cells, a dump gate 
with CD19 was used to eliminate non-specific staining, and staining of the same cell 
preparations with ‘empty’ tetramer (no αGalCer) confirmed specificity. Antibodies 
conjugated to fluorescein isothiocyanate, phycoerythrin, phycoerythrin-indotricarbocyanine, 
peridinine chlorophyll protein complex 5.5, allphycocyanin or allophycocyanin-
indotricarbocyanine were as follows: anti-IL-4 (11B11), -IFN-γ (XMG1,2), -IL-10 
(JES5-16E3), -CD44 (IM7), -TCRβ (G572597), -CD11b (M1/70), -CD11c (N418), -F4/80 
(CI:A3-1), -NK1.1 (PK136), -CD3 (500A2), -CD4 (RM4-5), and -CD25 (PC61). For 
staining for transcription factors anti-PLZF(9E12), -Tbet (4B10), -Gata3 (16E10A23), -
RORγt (B2D), -Foxp3 (FJK-16s), and -E4BP4 (S2M-E19) and cytokines, cells 
permeabilized with the Foxp3 staining buffer set (eBioscience). Cell doublets were excluded 
by comparison of side-scatter width to forward-scatter area.
In Vivo Stimulation of iNKT Cells and Intracellular Cytokine Staining
Mice were injected i.p. with 1 µg of αGalCer or vehicle alone and sacrificed after 5 hr or 4 
days. Single-cell suspension of splenocytes, liver mononuclear cells, and adipose tissue 
SVFs were obtained as before, but with the inclusion of Brefeldin A in all media. First, 
single-cell suspensions of splenocytes or LMNCs were stained with cell-surface-labeling 
CD3 mAb and αGalCer -loaded CD1d tetramer. Cells were then fixed, permeabilized, and 
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stained intracellularly for IL-4, IL-10, and IFN-γ using the Cytofix/Cytoperm kit (BD 
Biosciences), according to the manufacturer’s instructions. To neutralize cytokines prior to 
αGalCer treatment, anti-IL-4 (11B11) or anti-IL-10 (JES5-2A5) were injected i.p. prior to 
injection of αGalCer.
Statistics
Results are expressed as the mean ± S.E.M. The statistical tests used included unpaired 
Student’s t test using Welch’s correction for unequal variances and one-way analysis of 
variance followed by Tukey’s post-hoc test. P ≤ _0.05 was considered to denote 
significance. No exclusion of data points or mice was used. Pilot studies were used for 
estimation of the sample size required to ensure adequate power. Mice that received 
treatment were randomized per cage so that each cage contained mice with test treatment 
versus control treatment (ie. aGalCer vs vehicle).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. iNKT cells are tissue resident in adipose tissue and do not rely on ICAM or LFA1 for 
retention
(a) Relative frequencies of CD45.1 (host) and CD45.2 (parabiotic partner) lymphocytes in 
the blood, spleen, liver and adipose tissue of the CD45.1 member of a CD45.1 and CD45.2 
congenic C57BL/6 parabiotic pair joined at 6 wk of age and examined 2 weeks later. Shown 
are representative facs plots from 2 experiments in 5 pairs of mice each (n=20 mice). Graph 
shows chimerism of total lymphocytes in each organ in the parabiotic pairs (n=10 pairs). (b) 
Pie charts indicate the average of the relative frequencies of CD45.1 (black) and CD45.2 
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(grey) lymphocyte subsets in each partner after 15 d parabiosis (n=10 pairs). Results were 
generated after B cells, CD8+ and CD4+ T cells, Tregs, and iNKT cells were gated, in blood, 
spleen, liver and fat. (c) Representative dot plots of iNKT cell chimerism (as measured by 
CD45.1 and CD45.2) in blood and adipose compared to other non-iNKT T cells in adipose 
in a CD45.1 partner of parabiotic pair. (d) iNKT cell levels, as a % of lymphocytes, in liver 
and adipose in WT and ICAM1−/− mice (n=10 per group). (e) iNKT cell numbers in liver 
and adipose in WT and ICAM1−/− mice (n=5 per group). (f) WT mice were injected with 
anti-LFA and anti-ICAM1 and iNKT cell levels were measured in liver and fat the following 
day. Graphs represent one (n=4) of two independent experiments. Statistical comparisons 
using student t-test. *p<0.05, **p=<0.01.
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Figure 2. Adipose iNKT cells lack PLZF and are present in PLZF−/− mice
(a) Microarray analysis. Normalized expression values for transcripts isolated from iNKT 
cells from epididymal fat versus spleen of 6-week-old B6 males. (b) PLZF expression levels 
of iNKT cells from matched spleen and adipose tissue. Red dotted line represents the 
expression cut-off level. (c) PLZF-GFP mice were used to measure PLZF expression by 
flow cytometry. iNKT cells were gated in each organ and GFP+ cells were measured. 
Histogram illustrates matched organs from one mouse, data is representative of 9 mice. (d) 
Levels of iNKT cells in adipose tissue with age, as a % of total adipose T cells. n=4 mice per 
age group. (e) GFP+ cells gated on iNKT cells in thymus, liver and adipose, from PLZF-
GFP mice age 2, 4 and 8 weeks old. Histograms represent 4 mice per age group. (f) PLZF 
MFI expression on thymic, hepatic and adipose iNKT cells compared to adipose (non-
iNKT) T cells (white) Each timepoint = n=4 mice. (g) Representative contour plots of iNKT 
cell levels in thymus and adipose in PLZF+/+, PLZF+/− and PLZF−/− littermates. Right: 
Graph of reduced iNKT cell levels in PLZF+/− (n=7) and PLZF−/− (n=4) compared to WT 
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mice (n=5). * represents statistical significance compared to WT littermate mice. Statistical 
comparisons using ANOVA and Tukey post-hoc test. *p<0.05, **p=<0.01, ***p<0.001.
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Figure 3. Adipose iNKT cells have similar characteristics to PLZF negative iNKT cells
(a) Contour plots of NK1.1 and CD44 in matched thymic and adipose iNKT cells. (b) Graph 
represents the % of thymic, hepatic and adipose iNKT cells expressing CD24, CD44, NK1.1 
and CD4 on, n=3 mice per organ. (c) IL-2 mRNA levels in iNKT cells from thymus, spleen 
and adipose tissue, as well as Tregs from adipose tissue. (d) Graph of IL-2 production by 
splenic and adipose iNKT cells measured by flow cytometry of intracellular staining of IL-2 
after 4 hour stimulation with PBS or PMA and Ionomycin (PMA+I) (n=4). (e) Histogram of 
IL-2 intracellular staining gated on adipose iNKT cells in PLZF+/+ and PLZF−/− mice after 4 
hours of PMA+I stimulation with Brefeldin A, representative of n=4 per group (f) IL-2R 
mRNA levels in iNKT cells from thymus, spleen and adipose tissue, as well as Tregs from 
adipose tissue. Dotted line represents the expression cut-off value. Statistical comparisons 
using ANOVA and Tukey post-hoc test. *p<0.05, **p=<0.01, ***p<0.001.
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Figure 4. Adipose iNKT cells express E4BP4 which induces IL-10 production
(a) mRNA levels of E4BP4 (Nfil3) in iNKT cells from thymus, spleen, liver and adipose 
tissue, as wells as Tregs from adipose and spleen as comparison. (b) Representative 
histogram of intracellular staining for E4BP4 in iNKT cells in several organs and adipose 
(red), and isotype control (grey filled) (n=4 mice, same mice for each organ). (c) 
Representative histogram comparing intracellular staining of E4BP4 in adipose iNKT cells 
vs. adipose Tregs cells (B&C) representative of n=6. (d) Graph of E4BP4 expression (MFI) 
by flow cytometry gated on adipose and splenic CD4+ and CD8+ T cells after Tregs and 
iNKT cells were excluded, compared to adipose and splenic Tregs and iNKT cells (n=5). (e) 
Representative dot plot of Foxp3 staining and tetramer staining after gating on adipose 
TCRβ+ cells, and histogram of Foxp3 levels in iNKT cells and Tregs cells from adipose 
tissue (representative of n=8). (f) Intracellular staining of IL-10 in adipose iNKT cells after 
4hrs stimulation in vivo following PBS or αGalCer injection, representative of n=6 mice. (g) 
Primary splenic iNKT cell lines were transfected with E4BP4 (red lines) or mock transfected 
(grey). Representative histogram of E4BP4 expression 18 hrs after transfection. (h) 
Lynch et al. Page 22
Nat Immunol. Author manuscript; available in PMC 2015 July 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Intracellular levels of IL-10 levels and (i) mRNA levels of IL-10 in iNKT cells transfected 
with E4BP4 or mock transfected (n=3 cell lines transfected and mock transfected).
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Figure 5. Adipose iNKT cells interact with macrophages in vivo and induce M2 macrophages 
through IL-10
(a&b) Confocal images of CD1d tetramer labeling and CXCR6-GFP+ cells, co-stained with 
CD11b or CD4, in whole adipose tissue sections from WT and CXCR6-GFP+ mice 4 days 
after treatment with vehicle control or αGalCer (representative of 5 mice per treatment). (c) 
Quantification of iNKT-macrophage interactions. Number of iNKT cells after vehicle or 
αGalCer treatment per field (Left group), number of iNKT cells co-localizing with 
macrophages (middle group), and quantification of % of total iNKT cells interacting with 
macrophages per field after vehicle or αGalCer treatment (right group). (d) 
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Immunofluorescent microscopy staining for macrophages in whole mount adipose tissue 3 
days after in vivo PBS or αGalCer treatment. CD68 (red), CD206/MMR (green) and double 
positive ‘M2 phenotype’ macrophages (merged yellow cells). (e) Representative histograms 
of CD11c, CD206 and CD301 levels after gating on CD11b+F480+ macrophages in adipose 
tissue. Graphs of CD206+ (n=7) and CD301+ F480+ (n=4) macrophages in each mouse after 
treatment in vivo with PBS or αGalCer. (f) qPCR of iNOS and Arginine (Arg1) levels over 
bActin in whole adipose tissue after vehicle or αGalCer treatment in WT and CD1d−/− mice 
(n=3 per group). (g) Surface CD11c+ and (h) intracellular levels of iNOS in adipose 
macrophages in WT and CD1d−/− mice (n=3 per group). (i) In vivo treatment of WT mice 
with PBS or αGalCer (aGC) was repeated, with the inclusion of an IL-10 neutralizing 
antibody (aIL-10). Graph of mean level of CD11c, CD206, CD301 and IL-10R on adipose 
macrophages (n=4–5). Statistical comparisons using t-tests or ANOVA for group of 3 with 
Tukey post-hoc test. *p<0.05, **p=<0.01, ***p<0.001.
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Figure 6. Adipose iNKT control adipose tissue Tregs through IL-2 production
(a) Gating strategy, and representative contour plots of adipose Tregs after PBS or αGalCer 
treatment. (b) Levels of Tregs as a % of adipose lymphocytes and (c) as % of adipose T cells, 
after treatment with PBS (n=8) or αGalCer (n=9). and (d) number of Tregs in adipose tissue 
after treatment with PBS or αGalCer (n=5). (e) Levels of splenic Tregs from the same mice 
after treatment with PBS or αGalCer (n=5). Treg cell levels and numbers were measured 3 
days post-injection. (f) Confocal images of CD1d tetramer labeling and Foxp3-GFP+ cells, 
co-stained with CD4, in whole adipose tissue sections from Foxp3-GFP+ mice that received 
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αGalCer (represents 4 mice). (g) Levels of Tregs as a % of adipose lymphocytes, in 6wk-old 
WT versus CD1d−/− mice (n=7 per strain). (h) Adipose Tregs were stained intracellularly 
with Ki67 in 6wk-old WT versus CD1d−/− mice (n=5). (i) Levels of Tregs as a % of adipose 
T cells, in 6wk-old and 6 month old WT (n=6 and n=4) versus Ja18−/− mice (n=9 and n=4). 
(j) Treatment of WT mice with PBS or αGalCer (n=5 per group) was repeated, with the 
inclusion of an IL-2 neutralizing antibody in one group of αGalCer treated mice, and Treg % 
and number were measured in adipose tissue. Statistical comparisons using t-tests or 
ANOVA for group of 3 with Tukey post-hoc test. *p<0.05, **p=<0.01, ***p<0.001.
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Figure 7. Adipose iNKT cells enhance the suppressive ability of Tregs and have similar functions 
to Tregs
(a) Dot plots and graph of Klrg1 surface expression on splenic Treg cells 
(CD3+CD4+Foxp3+) in spleen 3 days after PBS or αGalCer treatment, or in WT adipose 
tissue 3 days after PBS or αGalCer treatment, or in adipose tissue of CD1d−/− mice (n=5 per 
group). (b) Intracellular IL-10 production in vivo by Treg cells in spleen (first 2 bars) and 
adipose tissue (last 2 bars) after treatment in vivo with αGalCer (n=4). (c) Basal intracellular 
IL-10 production in vivo by adipose Tregs in WT and Ja18−/− mice (n=6). (d) 10,000 Tregs 
were isolated from adipose tissue that had been treated with PBS or αGalCer for 3 days 
(pooled from 5 mice per treatment group), and cultured with peritoneal macrophages. MFI 
of CD301 and CD206 levels were measured on cultured macrophages (n=3 experiments). (e) 
Klrg1, ICOS and PD-1 surface expression on iNKT cells from spleen and adipose tissue 
(n=5–6). (f) Peritoneal macrophages were isolated from WT mice and cultured for 48hrs 
with either iNKT cells or Treg cells from adipose tissue or media alone. After 48hrs of 
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culture, macrophages were stained for flow cytometric analysis of CD206/MMR and CD301 
levels (n=2 independent experiments). (g) Dot plots and graphs of intracellular iNOS levels 
in peritoneal macrophages from obese mice cultured with adipose Treg cells and iNKT cells 
for 24 hours. Statistical comparisons using t-tests or ANOVA for group of 3 with Tukey 
post-hoc test. *p<0.05, **p=<0.01, ***p<0.001.
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